14.91

0.47% -0.1199

Anika Therapeutics Inc (ANIK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$15.03

Offen:

$15.13

24-Stunden-Volumen:

80,583

Relative Volume:

1.17

Marktkapitalisierung:

$212.07M

Einnahmen:

$166.88M

Nettoeinkommen (Verlust:

$-74.18M

KGV:

-2.9408

EPS:

-5.07

Netto-Cashflow:

$1.14M

1W Leistung:

-1.32%

1M Leistung:

-14.27%

6M Leistung:

-40.21%

1J Leistung:

-42.08%

1-Tages-Spanne:

$14.77

$15.45

1-Wochen-Bereich:

$14.77

$15.79

52-Wochen-Spanne:

$14.77

$29.11

Anika Therapeutics Inc Stock (ANIK) Company Profile

Firmenname

Anika Therapeutics Inc

Sektor

Healthcare (1165)

Branche

Drug Manufacturers - Specialty & Generic (1)

Telefon

(781) 457-9000

Adresse

32 WIGGINS AVENUE, BEDFORD, MA

Mitarbeiter

288

Twitter

Nächster Verdiensttermin

2025-03-12

Neueste SEC-Einreichungen

ANIK's Discussions on Twitter

Vergleichen Sie ANIK mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ANIK Anika Therapeutics Inc	14.94	212.07M	166.88M	-74.18M	1.14M	-5.07
ZTS Zoetis Inc	163.50	72.50B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	14.96	47.08B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.15	45.99B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.32	17.38B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.87	14.05B	612.78M	-86.37M	-62.91M	-0.87

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-01	Bestätigt	Barrington Research	Outperform
2023-08-14	Hochstufung	Barrington Research	Mkt Perform → Outperform
2023-03-07	Herabstufung	Barrington Research	Outperform → Mkt Perform
2022-11-09	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-10-14	Fortgesetzt	Stephens	Equal-Weight
2022-03-09	Herabstufung	Barrington Research	Outperform → Mkt Perform
2022-03-09	Herabstufung	Stephens	Overweight → Equal-Weight
2021-11-16	Eingeleitet	Stephens	Overweight
2021-07-16	Eingeleitet	UBS	Neutral
2020-12-16	Hochstufung	Barrington Research	Mkt Perform → Outperform
2020-05-08	Herabstufung	Barrington Research	Outperform → Mkt Perform
2020-01-21	Hochstufung	Sidoti	Neutral → Buy
2020-01-10	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-11-05	Eingeleitet	BWS Financial	Sell
2019-09-24	Bestätigt	Barrington Research	Outperform
2019-09-23	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-07-25	Hochstufung	First Analysis Sec	Neutral → Strong Buy
2019-02-22	Herabstufung	First Analysis Sec	Outperform → Neutral
2019-02-22	Herabstufung	Sidoti	Buy → Neutral
2018-07-27	Hochstufung	Barrington Research	Mkt Perform → Outperform
2018-06-20	Herabstufung	Barrington Research	Outperform → Mkt Perform
2018-06-20	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2018-05-04	Hochstufung	Barrington Research	Mkt Perform → Outperform
2018-02-23	Herabstufung	Barrington Research	Outperform → Mkt Perform
2018-01-24	Hochstufung	First Analysis Sec	Equal-Weight → Overweight
2017-10-27	Bestätigt	Barrington Research	Outperform
2016-05-09	Hochstufung	Singular Research	BUY - Long-Term → Buy
2016-04-27	Herabstufung	Northland Capital	Outperform → Market Perform
2016-02-26	Bestätigt	Barrington Research	Outperform

Alle ansehen

Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten

09:08 AM

Viscosupplementation Market Is Booming Worldwide | Anika - openPR.com

09:08 AM

Apr 01, 2025

Europe Viscosupplementation Market Projected To Witness - openPR.com

Apr 01, 2025

Mar 31, 2025

Anika Therapeutics stock hits 52-week low at $14.9 By Investing.com - Investing.com South Africa

Mar 31, 2025

Anika Therapeutics stock hits 52-week low at $14.9 - Investing.com India

Mar 31, 2025

Mar 29, 2025

How the (ANIK) price action is used to our Advantage - news.stocktradersdaily.com

Mar 29, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Reduced by Charles Schwab Investment Management Inc. - Defense World

Mar 29, 2025

Mar 28, 2025

Hammertoe Solution Market Size, Trends 2031 By Key Players- - openPR.com

Mar 28, 2025

Mar 26, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 26, 2025

Mar 25, 2025

Europe Viscosupplementation Market Set to Witness Significant - openPR.com

Mar 25, 2025

Mar 23, 2025

Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World

Mar 23, 2025

Mar 18, 2025

Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions - TipRanks

Mar 18, 2025

Mar 17, 2025

Anika Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 17, 2025

Viscosupplementation Market Is Booming Worldwide | Anika Therapeutics Inc., Seikagaku Corporation - openPR.com

Mar 17, 2025

Q1 Earnings Forecast for ANIK Issued By Barrington Research - Defense World

Mar 17, 2025

Mar 16, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN

Mar 16, 2025

Mar 15, 2025

Anika Therapeutics (NASDAQ:ANIK) Stock Rating Upgraded by StockNews.com - Defense World

Mar 15, 2025

Barrington Research Lowers Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00 - Defense World

Mar 15, 2025

Mar 14, 2025

Anika Therapeutics (NASDAQ:ANIK investor three-year losses grow to 45% as the stock sheds US$26m this past week - Simply Wall St

Mar 14, 2025

Anika Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 14, 2025

Mar 13, 2025

Anika Therapeutics stock hits 52-week low at $15.34 By Investing.com - Investing.com Australia

Mar 13, 2025

Anika Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks

Mar 13, 2025

Anika Therapeutics stock hits 52-week low at $15.34 - Investing.com

Mar 13, 2025

Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips - Investing.com Australia

Mar 13, 2025